Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mri Interventions (MRIC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.0000 +6.67%
on 05/29/19
3.5000 -8.57%
on 05/16/19
-0.1500 (-4.48%)
since 05/13/19
3-Month
2.0100 +59.20%
on 04/22/19
3.5500 -9.86%
on 05/10/19
+0.1600 (+5.26%)
since 03/13/19
52-Week
1.3300 +140.60%
on 12/26/18
3.7375 -14.38%
on 01/11/19
+1.1000 (+52.38%)
since 06/13/18

Most Recent Stories

More News
MRI Interventions Announces Closing of $7.522 Million Private Placement

MRI Interventions, Inc. (OTCQB: MRIC) today announced the closing on May 17, 2019 of its previously disclosed private placement of shares of common stock, which resulted in gross proceeds of $7.522 million....

MRICD : 7.0500 (-2.08%)
MRIC : 3.2000 (unch)
PTC Therapeutics and MRI Interventions Announce Strategic Investment

SOUTH PLAINFIELD, N.J. and IRVINE, Calif. , May 9, 2019 /PRNewswire/ --   PTC Therapeutics, Inc. (NASDAQ: PTCT) and MRI Interventions, Inc. (OTCQB: MRIC) today announced a strategic equity...

PTCT : 40.01 (-4.05%)
MRIC : 3.2000 (unch)
PTC Therapeutics and MRI Interventions Announce Strategic Investment

PTC Therapeutics, Inc. (NASDAQ: PTCT) and MRI Interventions, Inc. (OTCQB: MRIC) today announced a strategic equity investment, with PTC purchasing $4.0 million in shares of MRI common stock. PTC and MRI...

PTCT : 40.01 (-4.05%)
MRIC : 3.2000 (unch)
MRI Interventions Reports 52% Increase in First Quarter Revenue

MRI Interventions, Inc. (OTCQB: MRIC) (the "Company") today announced financial results for its first fiscal quarter ended March 31, 2019.

MRICD : 7.0500 (-2.08%)
MRIC : 3.2000 (unch)
MRI Interventions, Inc. to Announce First Quarter 2019 Results on April 30

MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene therapy, today announced that it will...

MRICD : 7.0500 (-2.08%)
MRIC : 3.2000 (unch)
MRI Interventions Congratulates Dr. Clark Chen On First Patient Dosing In Minnesota For Phase 2 Glioblastoma Trial

MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company developing products designed for navigation, ablation, deep brain stimulation, biopsy, aspiration and gene therapy, today congratulates...

MRICD : 7.0500 (-2.08%)
MRIC : 3.2000 (unch)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.7279 (+0.59%)
TRLFF : 0.3178 (-0.87%)
AITB : 5.20 (+2.56%)
BICXD : 4.5400 (-9.02%)
MMNFF : 1.9949 (-7.02%)
ATEA : 5.6900 (+0.53%)
CWBHF : 11.0600 (-8.04%)
CVSI : 4.2000 (-2.78%)
DUOT : 0.8500 (+6.25%)
CRLBF : 9.0700 (-0.84%)
ARREF : 0.4940 (+1.90%)
CLOK : 0.9600 (+5.49%)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.2926 (-2.47%)
HEOFF : 0.9645 (+3.77%)
MJARF : 0.9354 (-1.38%)
ALEAF : 0.9667 (-0.34%)
OTCM : 31.1500 (+0.48%)
NUPMF : 1.5800 (+8.22%)
GLDLF : 0.6664 (+2.52%)
NMUS : 0.6500 (-9.52%)
NLST : 0.3200 (unch)
GBPT : 0.3000 (+5.93%)
IMLFF : 0.2640 (-2.22%)
KSHB : 4.4400 (-2.42%)
CORVF : 1.5341 (-4.12%)
ELLXF : 2.5600 (-0.31%)
RSSS : 2.3000 (-4.17%)
ISYRF : 0.9150 (+4.21%)
FLUX : 1.0900 (unch)
NWGI : 0.3000 (unch)
QBIO : 1.3000 (-2.99%)
WIZD : 0.1600 (unch)
MRMD : 2.0200 (-5.16%)
GRWG : 3.0200 (-1.31%)
BRTI : 0.1590 (-0.63%)
GTBP : 0.2860 (+2.14%)
MRIC : 3.2000 (unch)
DYAI : 5.90 (-1.17%)
GTBIF : 9.7800 (-6.86%)
MTAFF : 0.7943 (-1.68%)
EMHTF : 2.1400 (-5.31%)
ITHUF : 3.1400 (-4.22%)
ALYE : 3.5000 (-12.50%)
VTLR : 0.1400 (+7.69%)
ARHH : 1.3300 (-0.75%)
OWCP : 0.0156 (-2.50%)
STLHF : 0.5631 (-0.32%)
PPCB : 0.0073 (-8.75%)
ARTH : 0.3200 (-1.51%)
ACRGF : 18.7485 (+3.24%)
MRI Interventions Reports 36% Increase in Fourth Quarter Revenue and Record Quarterly ClearPoint(R) Cases

MRI Interventions, Inc. (OTCQB: MRIC) (the "Company") today announced financial results for its fourth fiscal quarter and full year ended December 31, 2018.

MRICD : 7.0500 (-2.08%)
MRIC : 3.2000 (unch)
MRI Interventions Announces Collaboration with Voyager Therapeutics for the Design, Manufacture and Supply of V-TAG(TM) Device

MRI Interventions, Inc. (OTCQB:MRIC) a platform neurosurgery company developing products designed to deliver navigation, ablation, deep brain stimulation, aspiration, biopsy and gene therapy today announced...

MRICD : 7.0500 (-2.08%)
VYGR : 24.24 (-1.78%)
MRIC : 3.2000 (unch)
MRI Interventions Announces Agreement with Siemens Healthineers For Interfacing with the Portfolio of Magnetom MRI Scanners

MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company developing products designed for navigation, ablation, deep brain stimulation, biopsy, aspiration and gene therapy, today announced...

MRICD : 7.0500 (-2.08%)
MRIC : 3.2000 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade MRIC with:

Key Turning Points

2nd Resistance Point 3.2000
1st Resistance Point 3.2000
Last Price 3.2000
1st Support Level 3.2000
2nd Support Level 3.2000

See More

52-Week High 3.7375
Last Price 3.2000
Fibonacci 61.8% 2.8178
Fibonacci 50% 2.5338
Fibonacci 38.2% 2.2497
52-Week Low 1.3300

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar